RxDoctor Payments DataLook up a doctor →

James Ross

Pulmonary Disease · Phoenix, AZNPI 1659324721

Payments from drug & device makers

$2,033,365in general payments, 2019–2025

Across 945 payments — averaging $2151.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche TCRC, Inc.$2M
  • AstraZeneca$2K
  • Boehringer Ingelheim$2K
  • GSK$2K
  • Sanofi$1K
  • Actelion Pharmaceuticals US, Inc.$1K
  • plus $10K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche TCRC, Inc.18$2,015,209
AstraZeneca116$2,401
Boehringer Ingelheim84$1,686
GSK113$1,565
Sanofi54$1,296
Actelion Pharmaceuticals US, Inc.42$1,118
Regeneron Healthcare Solutions, Inc.32$910
Mylan Specialty L.p.54$851
United Therapeutics Corporation36$735
Mallinckrodt Hospital Products Inc.33$724
Genentech USA, Inc.29$613
Insmed, Inc.27$559
Electromed, Inc.47$488
ANI Pharmaceuticals, Inc.24$395
Jazz Pharmaceuticals Inc.16$390
Sunovion Pharmaceuticals Inc.29$374
Takeda Pharmaceuticals U.S.A., Inc.17$364
Baxter Healthcare17$291
Philips North America LLC14$284
Biogen4$274
Harmony Biosciences LLC13$248
Pulmonx Corporation12$247
Merck12$231
Amgen10$189
Advanced Respiratory, Inc13$188
Novartis8$184
Verona Pharma, Inc.6$178
Stryker1$146
Grifols USA, LLC7$143
ZOLL Respicardia, Inc.6$124
Gilead7$104
AbbVie4$99
Viatris Specialty LLC4$92
Teva Pharmaceuticals USA, Inc.4$65
Mallinckrodt Enterprises LLC2$53
UCB, Inc.3$52
Circassia Inc.3$49
Shionogi Inc2$46
Paratek Pharmaceuticals, Inc.3$38
Lilly USA, LLC2$32
Pharming Healthcare, Inc.1$30
Idorsia Pharmaceuticals US Inc2$29
Vifor Pharma, Inc.1$27
Covis Pharma GmbH1$26
Avadel CNS Pharmaceuticals, LLC1$23
Inogen, Inc.1$21
Vanda Pharmaceuticals Inc.1$21
CSL Behring1$20
Inspire Medical Systems, Inc.1$20
Phadia US Inc.1$19
Shire North American Group Inc1$19
Abiomed1$19
Nabriva Therapeutics, PLC1$16
Veran Medical Technologies, Inc.1$15
Itamar Medical Inc1$13
Arbor Pharmaceuticals, Inc.1$11

How this compares

$2,033,365 in reported general payments places this provider in the 95th percentile of 250 pulmonary disease providers in Arizona.

See all pulmonary disease providers in Arizona →

Other pulmonary disease in Phoenix

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →